Nicholas A. Jones

1.5k total citations
27 papers, 1.1k citations indexed

About

Nicholas A. Jones is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Nicholas A. Jones has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 10 papers in Cellular and Molecular Neuroscience and 6 papers in Molecular Biology. Recurrent topics in Nicholas A. Jones's work include Cannabis and Cannabinoid Research (15 papers), Neuroscience and Neuropharmacology Research (10 papers) and Epilepsy research and treatment (5 papers). Nicholas A. Jones is often cited by papers focused on Cannabis and Cannabinoid Research (15 papers), Neuroscience and Neuropharmacology Research (10 papers) and Epilepsy research and treatment (5 papers). Nicholas A. Jones collaborates with scholars based in United Kingdom, United States and Italy. Nicholas A. Jones's co-authors include Benjamin J. Whalley, Claire Williams, Gary J. Stephens, Andrew J. Hill, Imogen Smith, Sarah Bevan, Yuki Yamasaki, Colin Stott, Satoshi Akiyama and Michaël Bazelot and has published in prestigious journals such as Physiological Reviews, Neurology and Endocrinology.

In The Last Decade

Nicholas A. Jones

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas A. Jones United Kingdom 14 712 535 260 201 197 27 1.1k
Lyndsey L. Anderson Australia 17 576 0.8× 567 1.1× 356 1.4× 245 1.2× 63 0.3× 41 1.1k
Misty D. Smith United States 22 184 0.3× 848 1.6× 600 2.3× 521 2.6× 104 0.5× 40 1.5k
Gemma L. Baillie United Kingdom 13 1.4k 1.9× 892 1.7× 52 0.2× 506 2.5× 229 1.2× 19 1.8k
Daniele Bolognini United Kingdom 21 813 1.1× 537 1.0× 41 0.2× 586 2.9× 149 0.8× 29 1.5k
Jenny L. Wilkerson United States 21 766 1.1× 439 0.8× 66 0.3× 328 1.6× 113 0.6× 53 1.4k
Guillermo Moreno‐Sanz United States 17 822 1.2× 280 0.5× 26 0.1× 219 1.1× 134 0.7× 26 1.0k
Cameron S. Metcalf United States 19 133 0.2× 501 0.9× 364 1.4× 242 1.2× 69 0.4× 50 852
Sonal P. Sanghani United States 14 371 0.5× 92 0.2× 81 0.3× 414 2.1× 282 1.4× 15 1.3k
Valentina Latina Italy 19 423 0.6× 324 0.6× 46 0.2× 315 1.6× 76 0.4× 32 1.1k
Aleksandra Właź Poland 16 218 0.3× 333 0.6× 186 0.7× 184 0.9× 42 0.2× 46 746

Countries citing papers authored by Nicholas A. Jones

Since Specialization
Citations

This map shows the geographic impact of Nicholas A. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas A. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas A. Jones more than expected).

Fields of papers citing papers by Nicholas A. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas A. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas A. Jones. The network helps show where Nicholas A. Jones may publish in the future.

Co-authorship network of co-authors of Nicholas A. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas A. Jones. A scholar is included among the top collaborators of Nicholas A. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas A. Jones. Nicholas A. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devinsky, Orrin, et al.. (2023). Cannabinoid treatments in epilepsy and seizure disorders. Physiological Reviews. 104(2). 591–649. 13 indexed citations
2.
McNamara, A., Hiroshi Momiji, Karen Featherstone, et al.. (2021). Transcription Factor Pit-1 Affects Transcriptional Timing in the Dual-Promoter Human Prolactin Gene. Endocrinology. 162(4). 5 indexed citations
3.
Stott, Colin, et al.. (2019). Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent. Cannabis and Cannabinoid Research. 5(2). 145–149. 47 indexed citations
5.
Patra, Pabitra Hriday, Melissa Barker‐Haliski, H. Steve White, et al.. (2018). Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models. Epilepsia. 60(2). 303–314. 115 indexed citations
7.
Stott, Colin, et al.. (2017). The Effect of Cannabidiol on Human CNS-Expressed Voltage-Gated Sodium Channels (P1.228). Neurology. 88(16_supplement). 1 indexed citations
8.
Jones, Nicholas A., James Boyd, Antony Adamson, et al.. (2016). Dynamic NF-κB and E2F interactions control the priority and timing of inflammatory signalling and cell proliferation. eLife. 5. 47 indexed citations
9.
Jones, Nicholas A., Thomas G. Hill, Colin Stott, & Stephen Wright. (2016). Assessment of the Anticonvulsant Effects and Tolerability of GW Pharmaceuticals’ Cannabidiol in the Anticonvulsant Screening Program (P2.038). Neurology. 86(16_supplement). 2 indexed citations
10.
Jones, Nicholas A., Andrew J. Hill, Thomas G. Hill, et al.. (2015). Assessment of the Anticonvulsant Effects and Tolerability Profile of Cannabidiol: GW Pharmaceuticals’ Preclinical Program (I6-5A). Neurology. 84(14_supplement). 1 indexed citations
11.
Jones, Nicholas A., Andrew J. Hill, Thomas G. Hill, et al.. (2015). Assessment of the Anticonvulsant Effects and Tolerability Profile of Cannabidiol: GW Pharmaceuticals’ Preclinical Program (P4.255). Neurology. 84(14_supplement). 1 indexed citations
12.
Hill, Andrew J., Nicholas A. Jones, Imogen Smith, et al.. (2014). Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se. Neuroscience Letters. 566. 269–274. 73 indexed citations
13.
Jones, Nicholas A., Satoshi Akiyama, Andrew J. Hill, et al.. (2012). Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures. Seizure. 21(5). 344–352. 193 indexed citations
14.
Qin, Jun, Wei Zhou, Xianhai Huang, et al.. (2011). Discovery of a Potent Pyrazolopyridine Series of γ-Secretase Modulators. ACS Medicinal Chemistry Letters. 2(6). 471–476. 22 indexed citations
15.
Hill, Andrew J., Nicholas A. Jones, Imogen Smith, et al.. (2010). Δ9‐Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats. Epilepsia. 51(8). 1522–1532. 90 indexed citations
16.
Qin, Jun, Xianhai Huang, Mihirbaran Mandal, et al.. (2010). Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 21(2). 664–669. 19 indexed citations
17.
Hill, Andrew J., Nicholas A. Jones, Claire Williams, Gary J. Stephens, & Benjamin J. Whalley. (2009). Development of multi-electrode array screening for anticonvulsants in acute rat brain slices. Journal of Neuroscience Methods. 185(2). 246–256. 40 indexed citations
18.
Jones, Nicholas A., Andrew J. Hill, Imogen Smith, et al.. (2009). Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo. Journal of Pharmacology and Experimental Therapeutics. 332(2). 569–577. 257 indexed citations
19.
Jones, Nicholas A., Ian R. Hill, Snow Stolnik, et al.. (2000). Polymer chemical structure is a key determinant of physicochemical and colloidal properties of polymer–DNA complexes for gene delivery. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1517(1). 1–18. 77 indexed citations
20.
Jones, Nicholas A. & K.D. Baker. (1986). An Intelligent Knowledge-Based System Tool for High-Level BIST Design.. International Test Conference. 743–749. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026